Jessica focuses on European law and the regulation of medicinal products and medical devices, including in vitro diagnostic medical devices. She helps guide life sciences companies through the regulatory processes and technical requirements governing the approval and marketing of their products – from classification, clinical trials and audits to promotion and marketing. Jessica provides strategic advice from the early development stages to placing on the market and post-marketing activities. She also assists clients in their interactions with regulatory authorities, notified bodies and business partners.

Download full bio 


  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 


  • Université Catholique de Louvain
    Master in European Law, with honors , 2017

Admissions & Credentials

Brussels (A List)